Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05282212 · ClinicalTrials.gov registry record
Point of Care, High Resolution and 3-Dimensional Ultrasonography
A clinical trial of Dental Diseases and Bone Loss in Jaw, sponsored by University of Michigan.
- Completed
- Registry status
- 41
- Enrollment target
- 1
- Study location
NCT05282212: Completed study of Dental Diseases and Bone Loss in Jaw, sponsored by University of Michigan.
NCT05282212 is a study of Dental Diseases and Bone Loss in Jaw that has completed, run by University of Michigan. The registered enrollment target is 41 participants, below the 823-participant average among 3 other Dental Diseases trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05282212, a study of Dental Diseases and Bone Loss in Jaw, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall purpose of this study is to establish an ultrasound technique to aid in oral and dental examination of soft and hard tissues. Ultrasound is currently not used in Dentistry and associated oral examinations and we are exploring its usefulness for clinical practice. This study will investigate the use of ultrasonic imaging for planning and placing dental implants, as well as evaluate the use of ultrasonic imaging for monitoring marginal bone loss around dental implants.
Primary Outcome
The difference between ultrasound-determined measurements and intraoperative measurements (optical scanner images as indirect measurements)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Ultrasound Scan
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-03-09 |
| Est. Completion | 2023-08-31 |
What the finished NCT05282212 record still lists
NCT05282212 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 823-participant average among 3 other Dental Diseases trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Dental Diseases appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound Scan is the first listed.
NCT05282212 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05282212 about?
NCT05282212 is a clinical study titled "Point of Care, High Resolution and 3-Dimensional Ultrasonography". The overall purpose of this study is to establish an ultrasound technique to aid in oral and dental examination of soft and hard tissues. Ultrasound is currently not used in Dentistry and associated oral examinations and we are exploring its usefulness for clinical practice. This study will investig...
What is the current status of trial NCT05282212?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2022-03-09. Estimated completion is 2023-08-31.
What conditions does trial NCT05282212 study?
This clinical trial studies the following conditions: Dental Diseases, Bone Loss in Jaw.
What interventions are being tested in trial NCT05282212?
The interventions under investigation include: Ultrasound Scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05282212?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05282212 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI